China’s Fosun Pharma Cleared To List IPO On Hong Kong Exchange
This article was originally published in PharmAsia News
Executive Summary
Shanghai Fosun Pharmaceutical won clearance to conduct an initial public offering on the Hong Kong Stock Exchange, seeking to raise about $100 million.